startups digital health weight loss glp-1 platforms What's next for innovation: A primer on the race reshaping pharma and chronic disease care The unknown trajectory of GLP-1 – What's next for GLP-1 innovation:

Theyre often marketed under names like Mounjaro patches or Wegovy patches, but this is misleading because they do not contain any GLP-1 receptor agonist medications, such as semaglutide or tirzepatide

These factors have particularly impacted individuals with lower health literacy, food/nutrition literacy, and socioeconomic statusperpetuating health inequities for diet-related diseases [248,251]

Blood glucose levels in diabetic patients usually begin to stabilise during this period

The hair pull test, where a clinician gently pulls on a cluster of about 60 hairs, will yield six or more hairs in active telogen effluvium, compared to one or two normally